Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
Oxytocin to Enhance Integrated Treatment for AUD and PTSD

The primary objective of the proposed Stage II study is to examine the efficacy of oxytocin (OT) as compared to placebo in reducing (1) alcohol use disorder (AUD) symptoms, and (2) post

anxiety
substance use
functional magnetic resonance imaging
mood disorder
oxytocin
  • 0 views
  • 27 Dec, 2021
  • 1 location
Does Oxytocin Alter Tolerance to or Motivation for Alcohol

This pilot study will seek evidence that oxytocin, compared to placebo, reverses tolerance and alcohol seeking in humans.

Accepts healthy volunteers
  • 0 views
  • 23 Apr, 2022
  • 1 location
Intranasal Oxytocin for the Treatment of Alcohol Use Disorder

Primary: The primary objective of the study is to compare the efficacy of intranasal oxytocin in reducing the weekly percentage of heavy drinking days over the 10 weeks of maintenance treatment

  • 3 views
  • 04 Oct, 2022
  • 3 locations
Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain

. There is a need to develop new treatments to help manage chronic pain. The use of a nasal spray containing manufactured oxytocin may improve pain management. Oxytocin is produced in the human body and

fibromyalgia
chronic pain
pain relieving
pain relief
  • 0 views
  • 07 Oct, 2022
  • 3 locations
The Role of Oxytocin in the Second Stage of Labor (ROSSoL)

This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

Oxytocin (OT) is a hypothalamic peptide that enters the peripheral circulation via the posterior pituitary gland. OT plays a key role in regulating appetite, psychopathology, prosocial behavior

Accepts healthy volunteers
  • 0 views
  • 07 Apr, 2022
  • 1 location
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Oxytocin (OT) is a hypothalamic peptide that enters the peripheral circulation via the posterior pituitary gland. OT plays a key role in regulating appetite, psychopathology, prosocial behavior

Accepts healthy volunteers
  • 0 views
  • 07 Apr, 2022
  • 1 location
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome

This study is a phase 2 randomized double blind 8-week treatment trial of intranasal OXT vs. placebo in 50 subjects aged 5 to 17 years with PWS in order to assess IN-OXT's affect on measurements of (1) eating behaviors (2) repetitive behaviors (3) weight and body composition (4) quality of …

growth hormone
glucagon-like peptide-1
hormone levels
insulin
glucagon
  • 33 views
  • 04 Oct, 2022
  • 1 location
Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome (DYSMOT)

This phase 3 is designed to test the effectiveness of intranasal Oxytocin on Prader Willi Syndrome (PWS). This is a prospective, multicentre, randomised, double-blind, Phase 3 clinical

  • 0 views
  • 03 Jun, 2022
  • 1 location
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine

This study will investigate if an intra-nasal nose spray of the drug oxytocin can decrease the amount of pressure needed from the automatic Continuous Positive Airway Pressure (CPAP) device

obstructive sleep apnea
continuous positive airway pressure
  • 214 views
  • 24 Mar, 2022
  • 1 location